Longitudinal changes in zinc transport kinetics, metallothionein and zinc transporter expression in a blood-brain barrier model in response to a moderately excessive zinc environment

被引:27
|
作者
Bobilya, Dennis J. [1 ]
Gauthier, Nicole A. [1 ]
Karkia, Shakun [1 ]
Olley, Bryony J. [1 ]
Thomas, W. Kelly [2 ]
机构
[1] Univ New Hampshire, Dept Anim & Nutr Sci, Durham, NH 03824 USA
[2] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA
来源
JOURNAL OF NUTRITIONAL BIOCHEMISTRY | 2008年 / 19卷 / 02期
关键词
zinc homeostasis; zinc toxicity; blood-brain barrier; zinc transporters; metallothionein;
D O I
10.1016/j.jnutbio.2007.06.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A blood-brain barrier (BBB) model composed of porcine brain capillary endothelial cells (BCEC) was exposed to a moderately excessive zinc environment (50 mu mol/L Zn) in cell culture, and longitudinal measurements were made of zinc transport kinetics, ZnT-1 (SLC30A1) expression and changes in the protein concentration of metallothionein (MT), ZnT-1, ZnT-2 (SLC30A2) and Zip1 (SLC39A1). Zinc release by cells of the BBB model significantly increased after 12-24 h of exposure, but decreased back to control levels after 48-96 h, as indicated by transport across the BBB from both the ablumenal (brain) and the lumenal (blood) directions. Expression of ZnT-1, the zinc export protein, increased by 169% within 12 h, but was no longer different from controls after 24 h. Likewise, ZnT-1 protein content increased transiently after 12 h of exposure, but returned to control levels by 24 h. Capacity for zinc uptake and retention increased from both the lumenal and the ablumenal directions within 12-24 h of exposure and remained elevated. MT and ZnT-2 were elevated within 12 h and remained elevated throughout the study. Zip I was unchanged by the treatment. The BBB's response to a moderately high zinc environment was dynamic and involved multiple mechanisms. The initial response was to increase the cells' capacity to sequester zinc with additional MT and to increase zinc export with the ZnT-1 protein. But the longer-term strategy involved increasing ZnT-2 transporters, presumably to sequester zinc into intracellular vesicles as a mechanism to protect the brain and to maintain brain zinc homeostasis. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [41] The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice
    Kim, GW
    Lewén, A
    Copin, JC
    Watson, BD
    Chan, PH
    NEUROSCIENCE, 2001, 105 (04) : 1007 - 1018
  • [42] MicroRNA-30a regulates acute cerebral ischemia-induced blood-brain barrier damage through ZnT4/zinc pathway
    Wang, Peng
    Pan, Rong
    Weaver, John
    Jia, Mengjie
    Yang, Xue
    Yang, Tianhui
    Liang, Jia
    Liu, Ke J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (03): : 641 - 655
  • [43] Transient changes in blood-brain barrier integrity, thermotolerance, and heat shock protein expression following brief hyperthermia in an in vitro model
    Bobilya, Dennis
    Klein, Courtney
    FASEB JOURNAL, 2008, 22
  • [44] Transient changes in blood-brain barrier integrity, thermotolerance, and heat shock protein expression following brief hyperthermia in an in vitro model
    Klein, Courtney
    Bobilya, Dennis
    FASEB JOURNAL, 2008, 22
  • [45] Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport
    Veszelka, Szilvia
    Toth, Andras
    Walter, Fruzsina R.
    Toth, Andrea E.
    Grof, Ilona
    Meszaros, Maria
    Bocsik, Alexandra
    Hellinger, Eva
    Vastag, Monika
    Rakhely, Gabor
    Deli, Maria A.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [46] Permeability, changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells
    Winter, Sven
    Konter, Joerg
    Scheler, Stefan
    Lehmann, Jochen
    Fahr, Alfred
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2008, 18 (03): : 229 - 239
  • [47] Blood-Brain Barrier Permeability is Affected by Changes in Tight Junction Protein Expression at High-Altitude Hypoxic Conditions-this may have Implications for Brain Drug Transport
    Liu, Guiqin
    Wang, Qian
    Tian, Lu
    Wang, Mengyue
    Duo, Delong
    Duan, Yabin
    Lin, Yue
    Han, Junjun
    Jia, Qiangqiang
    Zhu, Junbo
    Li, Xiangyang
    AAPS JOURNAL, 2024, 26 (05):
  • [48] Differential kinetics of transport of 2,3′-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood-brain barrier
    Li, JY
    Boado, RJ
    Pardridge, WM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (02): : 735 - 740
  • [49] Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts
    Uemura, Tatsuki
    Ito, Shingo
    Masuda, Takeshi
    Shimbo, Hiroko
    Goto, Tomohide
    Osaka, Hitoshi
    Wada, Takahito
    Couraud, Pierre-Olivier
    Ohtsuki, Sumio
    PHARMACEUTICAL RESEARCH, 2020, 37 (03)
  • [50] Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts
    Tatsuki Uemura
    Shingo Ito
    Takeshi Masuda
    Hiroko Shimbo
    Tomohide Goto
    Hitoshi Osaka
    Takahito Wada
    Pierre-Olivier Couraud
    Sumio Ohtsuki
    Pharmaceutical Research, 2020, 37